Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents

Lipids

Volumn 36, Issue 5, 2001, Pages 543-548

  Schindler, R ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; ENZYMES; ESTERS; METABOLISM; METABOLITES; VITAMINS;

PHARMACOLOGIC AGENTS; STANDARD INCUBATION CONDITIONS;

LIPIDS;

ALIMEMAZINE; AMIODARONE; AMITRIPTYLINE; BENCYCLANE; BROMOCRIPTINE; CEFOTIAM; CHLORAL HYDRATE; CHLORPROTHIXENE; CINNARIZINE; CLEMASTINE; CLOPENTHIXOL; CYCLANDELATE; CYCLOPHOSPHAMIDE; DICLOFENAC; DRUG METABOLITE; ERYTHROMYCIN; FLUPENTIXOL; GLIBORNURIDE; HYDROXYZINE; MEVINOLIN; MICONAZOLE; NAFTIDROFURYL; NIFEDIPINE; PHENOXYBENZAMINE; PHYSOSTIGMINE; PHYTOMENADIONE; PROBUCOL; QUINIDINE; RETINYL PALMITATE ESTERASE; SULFINPYRAZONE; THIORIDAZINE;

ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FIRST PASS EFFECT; HUMAN; HUMAN TISSUE; IC 50; LIVER; NONHUMAN; SWINE; VITAMIN METABOLISM;

ANIMALIA; SUS SCROFA;

EID: 0034976054     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-001-0755-z     Document Type: Article

References (40)

1. 3H) retinyl ester by rat liver: Evidence for retinol transfer from parenchymal to nonparenchymal cells
2. The enzymes and kinetics of hepatic retinol metabolism
3. Retinoids, retinoid-binding proteins, and retinyl palmitate hydrolase distribution in different types of rat liver cells
4. Hepatic Retinol Metabolism
5. Retinol esterification by rat liver microsomes
6. Esterification of retinol in rat liver
7. Lipases and carboxylesterases: Possible roles in the hepatic metabolism of retinol
8. Purification and characterization of retinyl ester hydrolase as a member of the non-specific carboxylesterase supergene family
9. Properties of liver retinyl ester hydrolase in young pigs
10. Mathematical analysis of the concentration-response relationships
11. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
12. Fluorometric determination of vitamin A in human blood and liver
13. Untersuchungen zur relativen bioverfügbarkeit und pharmakokinetic von chloralhydrat und seinen metaboliten
14. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses
15. 1) in humans
16. Vitamin K status in human tissues: Tissue-specific accumulation of phylloquinone and menaquinone-4
17. Clinical pharmacokinetics of cholinesterase inhibitors
18. Probucol; a reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia
19. The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine
20. Amiodarone and its desethyl metabolite: Tissue distribution and morphologic changes during long-term therapy
21. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics
22. Determination of naftidrofuryl in human plasma by high-performance liquid chromatography with fluorescence detection
23. Inhibition of chicken liver carboxylesterase by activated carbonyls and carbonyl hydrates
24. The cholinesterases: From genes to proteins
25. Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes
26. The functional size of acyl-coenzyme a (CoA):Cholesterol acyltransferase and acyl-CoA hydrolase as determined by radiation inactivation
27. Inhibition of acyl coenzyme A:Cholesterol acyl transferase by trimethylcyclohexanylmandelate (cyclandelate)
28. Inhibition of acyl coenzyme A:Cholesterol acyl transferase by 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
29. Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver
30. Oral naftidrofuryl - A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease
31. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver
32. Difference in the inhibition of plasma carboxylesterase activity by metoclopramide in humans and laboratory animals
33. Human cytochrome P450 3A4-catalyzed testosterone 6βHydroxylation and erythromycin N-demethylation
34. Molecular modeling of cytochrome P450 3A4
35. Pharmacokinetics and metabolism of the anti-inflammatory agent voltaren
36. Kinetics of chlorambucil in Vitro: Effects of fluid and matrix, human gastric juice, plasma proteins and red cells
37. Amiodarone induced modifications of the phospholipid physical study
38. Amiodarone pharmacokinetics
39. Lipidosis induced by amphiphilic cationic drugs
40. Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C